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Abstract. We report the synthesis and solid state structures of 1,3-di-aryl-imidazolin-2-ylidine-1,1-diphenyl-
phosphinamine [(aryl = mesityl (1a) and aryl = 2,6-diisopripyl (1b)] and their chalcogenide compounds 1,
3-di-aryl-imidazolin-2-ylidine-P,P -diphenylphosphinicamide (2a,b), 1,3-di-aryl-imidazolin-2-ylidine-P ,P -
diphenyl-phosphinothioicamide (3a,b) and 1,3-diaryl-imidazolin-2-ylidine-P,P -diphenyl-phosphinoselenoic-
amide (4a,b). The compounds 1a,b were prepared in good yield by the reaction of 1,3-di-aryl-imidazolin-2-
imine and chlorodiphenylphosphine in the presence of triethylamine in toluene. The reactions of 1a,b with ele-
mental sulphur and selenium afforded the corresponding chalcogenide compounds 3a,b and 4a,b respectively.
The corresponding oxo- derivative (2a,b) was obtained by reacting compound 1a,b with 30% aqueous hydro-
gen peroxide in THF. The molecular structures of 1a, 2a, 3a and 4a,b have been established by single crystal
X-ray diffraction analyses. The molecular structures reveal that even C1–N1–P1 angle (124.62◦) in compound 1a
is less obtuse compared to the corresponding C1–N1–Si1 angles (157.8◦) observed in related N -silylated 2-
iminoimidazolines and trimethylsilyl iminophosphoranes. C1–N1–P1 angles are further widened in compounds
2a, 3a, and 4a,b due to the attachment of chalcogen atoms onto phosphorus atom.
Keywords. Imidazol-2-imine; imidazolin-2-ylidene-1,1-diphenyl-phosphinamine; sulfide; selenide.
1. Introduction
N -heterocyclic carbenes (NHCs) of the imidazolin-2-
ylidene type1 are nowadays ubiquitous and essential in
research areas such as homogeneous catalysis,2 mate-
rials science3 and medicinal chemistry4 and they play
very important roles in organotransition metal and coor-
dination chemistry. Imidazolin-2-imines which can be
achieved by the reaction of N-heterocyclic carbenes of
the imidazolin-2-ylidene-type with organic azides such
as trimethylsilyl azide followed by desilylation, are
attractive precursors for the generation of mono-anionic
imidazolin-2- iminato ligands, used as ancillary ligands
to stabilize the early transition metals and metals in a
higher oxidation state. Imidazoline-2-iminato complexes
are widely used in a number of homogeneous catalysts,
in particular for olefin polymerization and alkyne me-
tathesis. Tamm et al., have shown that these ligands are
efficient for the synthesis of transition metal and lan-
thanide complexes,5 as imidazolin-2-imine ligands can
act as 2σ, 4π-electron donors analogous to related
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phosphoraneimides, R3PN−,6 cyclopentadienides, C5R−5 .
Imidazolin-2-imines can also be used as building blocks
for a number of multidentate ligands by linking the
imidazolin-2-imines fragment to each other or to other
functional moieties.7 Recently, we had reported our pre-
liminary results of extending the imidazolin-2-imine
ligand by phosphine group to get related imidazolin-2-
ylidene-1,1-diphenylphosphinamine and its chalcoge-
nide derivatives (O, S, Se, Te).8 In continuation to our
study, we were interested to expand our studies with
various imidazolin-2-imines. With this contribution, we
now wish to give a full account of the synthesis and
structural characterization of ImRNPPh2 [R = Mes (1a),
Dipp (1b)] and their respective chalcogenide com-
pounds ImRNP(= E)Ph2 [E = O, R = Mes, (2a), Dipp
(2b); E = S, R = Mes, (3a), Dipp (3b); E = Se, R =
Mes, (4a), Dipp (4b)].
2. Experimental
2.1 General Information
All manipulations were performed in an atmosphere
of dry nitrogen by using Schlenk-type glassware on a
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dual manifold Schlenk line, interfaced to a high vacuum
(10−4 torr) line. THF was pre-dried over Na wire and
distilled under nitrogen from sodium and benzophenone
ketyl prior to use. Toluene was distilled under nitrogen
from sodium. 1H NMR (400 MHz), 13C{1H} (100 MHz)
and 31P{1H} NMR (161.9 MHz) spectra were recorded
on a BRUKER AVANCE III-400 spectrometer. BRUKER
ALPHA FT-IR was used for FT-IR measurement. Ele-
mental analyses were performed on a BRUKER EURO
EA at the Indian Institute of Technology Hyderabad. 1,
3-di-aryl-imidazolin-2-imine (aryl = Mes or Dipp) was
prepared according to literature procedure.9 The NMR
solvent CDCl3 was purchased from Sigma Aldrich.
2.2 Synthesis of ImRNPPh2 [R =Mes (1a), Dipp (1b)]
Chlorodiphenylphosphine (0.393 g, 1.79 mmol) was
added dropwise over a period of 20 min to a stirred solu-
tion of 1,3-di-aryl imidazole-2-imine (1.79 mmol) and
triethylamine (0.181 g, 1.79 mmol) in dry toluene (5
mL). The reaction mixture was stirred at room temper-
ature for another 6 h. The white precipitate of triethy-
lammonium hydrochloride was filtered through a frit
in an inert atmosphere. In the filtrate, the solvent was
removed under vacuum to leave an orange solid. Com-
pound 1a was re-crystallized from toluene at –35◦C.
Orange crystals appeared after 2–3 days.
1a: Yield: 1.2 g, 90%). 1H NMR (400 MHz, CDCl3):
δ 7.22–7.13 (m, 6H, Ph), 7.03–6.95 (m, 4H, Ph), 6.77
(s, 4H, Ar), 6.59 (s, 2H, NCHCHN), 2.31 (s, 6H,
CH3), 2.18 (s, 12H, CH3) ppm. 31P{1H} NMR (161.9
MHz, CDCl3): δ 35.8 ppm. 13C{1H} NMR (100 MHz,
CDCl3): δ 141.2 (ipso-Ar), 140.1 (NCN), 138.92 (ipso-
Ph), 136.6 (o-Ar), 132.2 (p-Ar), 130.6 (o-Ph), 130.5 (o-
Ph), 128.9 (m-Ar), 128.7 (p-Ph), 126.9 (m-Ph), 126.8
(m-Ph), 115.5 (NCH), 21.0 (CH3), 18.4 (CH3) ppm.
FT-IR selected peak (cm−1): 924 (P-N), 1128 (P-Ph),
1653 (C=N), 3050 (aromatic C-H). Elemental analy-
sis: C33H34N3P (503.64): Calcd. (%) C 78.70, H 6.80, N
8.34; Found (%) C 78.44, H 6.57, N 8.04.
1b: Yield: 1.6 g (92%). 1H NMR (400 MHz, CDCl3):
δ 7.21-7.46 (m, 2H, Ar), 7.25-7.21 (m, 4H, Ar), 6.98-
6.93 (m, 10H, Ph), 6.39 (s, 2H, NCHCHN), 2.99 (sept,
4H, 3JHH = 6.36 Hz, CH (CH3)2), 1.18 (d, 12H, 3JHH =
6.84 Hz, CH(CH3)2), 1.04 (d, 12H, 3JHH = 6.84 Hz,
CH(CH3)2) ppm. 31P{1H}NMR (161.9 MHz, CDCl3):
δ 27.8 ppm. 13C{1H}NMR (100 MHz, CDCl3): δ 148.5
(NCN), 147.8 (ipso-Ar), 134.1 (ipso-Ph), 130.4 (o-Ar),
130.2 (p-Ar), 129.2 (o-Ph), 127.0 (m-Ar), 126.7 (p-
Ph), 123.5 (m-Ar), 115.1 (NCH), 28.8 (CH(CH3)2),
24.6 (CH(CH3)2), 24.6 (CH(CH3)2) ppm. Elemental
analysis: C39H46N3P (587.78): Calcd. (%) C 79.69, H
7.89, N 7.15; Found (%) C 79.39, H 7.42, N 6.88.
2.3 Synthesis of ImRNP(=E)Ph2[E=O, R =Mes, (2a),
Dipp (2b)
In a 50 mL of dry Schlenk flask 1 mmol of compound
1a or 1b was dissolved in 4 mL of THF. To this solu-
tion, H2O2 (1.5 equiv.) was added and kept for stirring
at ambient temperature. After four hours of stirring the
solvent was evaporated white solid was obtained; puri-
fied by column chromatography (EtOAc/Hexane). The
compound was re-crystallized from dichloromethane at
room temperature.
2a: Yield: 1.4 g, 93%). 1H NMR (400 MHz, CDCl3):
δ 7.19–7.13 (m, 6H, Ph), 7.06–6.98 (m, 4H, Ph), 6.89
(s, 4H, Ar), 6.47 (s, 2H, NCHCHN), 2.37 (s, 6H, CH3),
2.05 (s, 12H, CH3) ppm. 31P{1H}NMR (161.9 MHz,
CDCl3): δ 5.0 ppm. 13C{1H}NMR (100 MHz, CDCl3):
δ 139.6 (ipso-Ar), 138.9 (ipso-Ph), 138.2 (NCN), 136.9
(o-Ar), 132.2 (p-Ar), 131.1 (o-Ph), 131.0 (o-Ph), 129.2
(m-Ar), 128.8 (p-Ph), 127.1 (m-Ph), 127.0 (m-Ph),
114.7 (NCH), 21.0 (CH3), 17.8 (CH3) ppm. FT-IR
selected peak (cm−1): 915 (P-N), 1109 (P-Ph), 1260
(P=O), 1623 (C=N), 2962 (aromatic C-H). Elemental
analysis: C33H34N3OP (519.62): Calcd. (%) C 76.28, H
6.60, N 8.09; Found (%) C 75.91, H 6.31, N 7.88.
2b: Yield: 1.2 g, 90%. 1H NMR (400 MHz, CDCl3):
δ 7.48 (t, 2H, 3JHH = 7.84 Hz, p-Ar), 7.24 (d, 4H,
3JHH = 7.84 Hz, m-Ar), 7.14-7.01 (m, 6H, Ph), 7.00-
6.93 (m, 4H, Ph), 6.57 (s, 2H, NCHCHN), 2.86
(sept, 4H, 3JHH = 6.84 Hz, CH (CH3)2), 1.15 (d, 12H,
3JHH = 6.84 Hz, CH(CH3)2), 1.04 (d, 12H, 3JHH =
6.84 Hz, CH(CH3)2) ppm. 31P{1H}NMR (161.9 MHz,
CDCl3): δ 4.4 ppm. 13C{1H}NMR (100 MHz, CDCl3):
δ 147.4 (ipso-Ar), 145.5 (NCN), 140.2 (ipso-Ph), 138.9
(ipso-Ph), 133.0 (o-Ar), 131.2 (o-Ph), 131.1 (o-Ph),
129.8 (p-Ar), 129.0 (p-Ph), 127.2 (m-Ph), 127.0 (m-
Ph), 123.8 (m-Ar)116.0 (NCH), 28.9 (CH(CH3)2), 24.9
(CH(CH3)2), 22.3 (CH(CH3)2) ppm. FT-IR selected
peak (cm−1): 950 (P-N), 1110 (P-Ph), 1264 (P=O),
1625 (C=N), 2963 (aromatic C-H). Elemental analysis:
C39H46N3OP (603.78): Calcd. (%) C 77.58, H 7.68, N
6.96; Found (%) C 77.15, H 7.37, N 6.64.
2.4 Synthesis of [ImRNP(=E)Ph2] [E =S, R =Mes,
(3a), Dipp (3b)]
In a 50 mL of dry Schlenk flask 1 mmol of compound
1a or 1b was dissolved in 10 mL of toluene. To this
solution, elemental sulphur (1mmol) was added and the
solution was kept at 90◦C for 12 h under stirring. The
solvent was evaporated under vacuum and the crude
product obtained was purified by column chromatog-
raphy (EtOAc/hexane). The title compound was re-
crystallized from CH2Cl2/hexane at room temperature.
Chalcogenide compounds of imidazolin-2-ylidene-1,1-diphenyl-phosphinamine
3a: Yield: 0.62 g, 97%. 1H NMR (400 MHz, CDCl3):
δ 7.21-7.12 (m, 6H, Ph), 7.03-6.96 (m, 4H, Ph), 6.77 (s,
4H, Ar), 6.59 (s, 2H, NCHCHN), 2.31 (s, 6H, CH3),
2.18 (s, 12H, CH3) ppm. 31P{1H}NMR (161.9 MHz,
CDCl3): δ 35.8 ppm. 13C{1H}NMR (100 MHz, CDCl3):
δ 139.6 (ipso-Ar), 138.9 (ipso-Ph), 138.2 (NCN), 136.6
(o-Ar), 132.2 (p-Ar), 130.6 (o-Ph), 130.5 (o-Ph), 128.9
(m-Ar), 128.7 (p-Ph), 126.9 (m-Ph), 126.8 (m-Ph),
115.5 (NCH), 21.0 (CH3), 18.4 (CH3) ppm. FT-IR
selected peak (cm−1): 732 (P=S), 911 (P-N), 1434
(P-Ph), 1561 (C=N), 3052 (aromatic C-H). Elemental
analysis: C33H34N3PS (535.68): Calcd. (%) C 73.99, H
6.40, N 7.84; Found (%): C 73.56, H 6.12, N 7.36.
3b: Yield: 0.83 g, 96%. 1H NMR (400 MHz, CDCl3):
δ 7.43 (t, 2H, 3JHH = 7.84 Hz, p-Ar), 7.17 (d, 4H,
3JHH = 7.84 Hz, m-Ar), 7.13-7.04 (m, 6H, Ph), 7.00-
6.90 (m, 4H, Ph), 6.68 (s, 2H, NCHCHN), 3.00 (sept,
4H, 3JHH = 6.84 Hz, CH(CH3)2), 1.14 (d, 12H,
3JHH = 6.84 Hz, CH(CH3)2), 1.13 (d, 12H, 3JHH =
6.84 Hz, CH(CH3)2) ppm. 31P{1H}NMR (161.9 MHz,
CDCl3): δ 36.1 ppm. 13C{1H}NMR (100 MHz, CDCl3):
δ 147.5 (NCN), 147.2 (ipso-Ar), 141.8 (ipso-Ph), 140.6
(ipso-Ph), 133.0 (o-Ar), 130.6 (o-Ph), 130.5 (o-Ph),
129.8 (p-Ar), 128.7 (p-Ph), 127.0 (m-Ph), 126.9 (m-
Ph), 123.9 (m-Ar)116.9 (NCH), 28.7 (CH(CH3)2), 25.3
(CH(CH3)2), 22.6 (CH(CH3)2 ppm. FT-IR selected
peak (cm−1): 728 (P=S), 907 (P-N), 1467 (P-Ph),
1561 (C=N), 3055 (aromatic C-H). Anal Calc. for
C39H46N3PS (619.84): Calcd. (%) C 75.57, H 7.48, N
6.78; Found (%) C 75.09, H 7.21, N 6.59.
2.5 Synthesis of [ImRNP(=E)Ph2] [E =Se, R =Mes,
(4a), Dipp (4b)]
In a 50 mL of dry Schlenk flask 1equiv. of com-
pound 1a or 1b was dissolved in 10 mL of toluene
and to this solution elemental selenium (1.8 equiv.)
was added and kept for stirring at 90◦C for 12 h.
The solvent was evaporated under vacuum and a white
solid residue was obtained which was purified by col-
umn chromatography (EtOAc/hexane). The title com-
pound was re-crystallized from CH2Cl2/hexane at room
temperature.
4a: Yield: 0.63 g, 98%. 1H NMR (400 MHz, CDCl3):
δ 7.21-7.12 (m, 6H, Ph), 7.03-6.96 (m, 4H, Ph), 6.77
(s, 4H, Ar), 6.60 (s, 2H, NCH=CHN), 2.31 (s, 6H,
CH3), 2.21 (s, 12H, CH3) ppm. 31P{1H}NMR (161.9
MHz, CDCl3): δ 25.7 ppm. 13C{1H}NMR (100 MHz,
CDCl3): δ 140.3 (ipso-Ar), 139.3 (NCN), 137.9 (ipso-
Ph), 135.5 (o-Ar), 131.1 (p-Ar), 129.7 (o-Ph), 129.5 (o-
Ph), 127.9 (m-Ar), 127.7 (p-Ph), 127.7 (m-Ph), 114.7
(NCH), 20.0 (CH3), 17.7 (CH3) ppm. FT-IR selected
peak (cm−1): 965 (P=Se), 917 (P-N), 1615 (C=N),
3049 (aromatic C-H). Elemental analysis: C33H34N3PSe
(582.50): Calcd. (%) C 68.03, H 5.88, N 7.21; Found
(%) C 67.79, H 5.55, N 7.07.
4b: Yield: 0.47 g, 96%. 1H NMR (400 MHz, CDCl3):
δ 7.41 (t, 2H, 3JHH = 7.84 Hz, p-Ar), 7.16 (d, 4H,
3JHH = 7.76 Hz, m-Ar), 7.12-7.04 (m, 6H, Ph), 7.00-
6.90 (m, 4H, Ph), 6.71 (s, 2H, NCHCHN), 3.05 (sept,
4H, 3JHH = 6.36 Hz, CH (CH3)2), 1.17 (d, 12H, 3JHH =
6.84 Hz, CH(CH3)2), 1.14 (d, 12H, 3JHH = 6.84 Hz,
CH(CH3)2) ppm. 31P{1H}NMR (161.9 MHz, CDCl3):
δ 36.1 ppm. 13C{1H}NMR (100 MHz, CDCl3): δ 148.1
(NCN), 147.1 (ipso-Ar), 141.4 (ipso-Ph), 140.4 (ipso-
Ph), 132.8 (o-Ar), 130.7 (o-Ph), 130.6 (o-Ph), 129.9
(p-Ar), 128.7 (p-Ph), 127.0 (m-Ph), 126.9 (m-Ph),
124.0 (m-Ar), 117.2 (NCH), 28.7 (CH(CH3)2), 25.5
(CH(CH3)2), 22.8 (CH(CH3)2) ppm. FT-IR selected
peak (cm−1): 956 (P=Se), 908 (P-N), 1600 (C=N),
3054 (aromatic C-H). Elemental analysis: C39H46N3PSe
(666.74): Calcd. (%) C 70.26, H 6.95, N 6.30; found
(%) C 70.02, H 6.79, N 6.14.
2.6 Single-Crystal X-Ray Structure Determinations
2.6a X-ray Crystallographic Analyses: Single crys-
tals of compound 1a were grown from toluene at
–35◦C whereas crystals of 2a, 3a, 4a,b were grown
from CH2Cl2/hexane mixture at room temperature.
In each case, a crystal of suitable dimensions was
mounted on a CryoLoop (Hampton Research Corp.)
with a layer of light mineral oil and placed in a nitro-
gen stream at 150(2) K. All measurements were made
on an Agilent Supernova X-calibur Eos CCD detec-
tor with graphite-monochromatic Cu-Kα (1.54184 Å)
radiation. Crystal data and structure refinement param-
eters are summarized in the table 1. The structures
were solved by direct methods (SIR2004)10 and refined
on F 2 by full-matrix least-squares methods; using
SHELXL-97.11 Non-hydrogen atoms were anisotrop-
ically refined. H-atoms were included in the refine-
ment on calculated positions riding on their carrier
atoms. The function minimized was [
∑
w(Fo2−F c2)2]
(w = 1 / [σ 2 (Fo2) + (aP)2+ bP]), where P =
(Max(Fo2,0) + 2F c2) / 3 with σ 2(Fo2) from counting
statistics. The function R1 and wR2 were (‖Fo| −
|Fc‖) / |Fo| and [w(Fo2 − F c2)2 / (wFo4)]1/2,
respectively. The ORTEP-3 program12 was used to
draw the molecule. Crystallographic data (excluding
structure factors) for the structures reported in this
paper have been deposited with the Cambridge Crys-
tallographic Data Centre as a supplementary publi-
cation no. CCDC 1420028-1420032. Copies of the
data can be obtained free of charge on application
to CCDC, 12 Union Road, Cambridge CB21EZ, UK
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Table 1. Crystallographic details of 1, 2a, 3a, 4a and 4b.
Crystal 1 2a 3a
CCDC No. 1420028 1420029 1420030
Empirical formula C33H34N3P C33H34N3OP C33H34N3PS
Formula weight 503.60 519.60 535.66
T (K) 150(2) 293(2) 293(2)
λ (Å) 1.54184 1.54184 1.54184
Crystal system Triclinic Monoclinic Orthorhombic
Space group P1 P21/c P212121
a (Å) 8.8079(6) 8.4818(4) 8.7492(4)
b (Å) 10.3470(8) 31.2129(2) 18.4412(1)
c (Å) 16.7289(1) 14.0448(9) 18.4548(8)
α (◦) 89.195(6) 90 90
β (◦) 80.155(6) 103.174(6) 90
γ (◦) 69.595(7) 90 90
V ( Å3) 1406.1(2) 3620.4(4) 2977.6(3)
Z 2 4 4
Dcalc Mg m−3 1.189 0.953 1.195
μ (mm−1) 1.051 0.850 1.660
F (000) 536 1104 1136
Theta range for data collection 4.56 to 70.60◦ 3.52 to 69.99◦ 3.39 to 70.79◦.
Limiting indices −10<=h<=10, −10<=h<=10, −10<=h<=6,
−12<=k<=12, −37<=k<=37, −20<=k<=20,
−20<=l<=15 −12<=l<=17 −22<=l<=20
Reflections collected / unique 9935 / 5287 16013 / 6827 6407 / 4510
[R(int) = 0.0220] [R(int) = 0.0314] [R(int) = 0.0208]
Completeness to theta 97.7% 99.0% 88.5%
Absorption correction Multi-Scan Multi-Scan Multi-Scan
Max. and min. transmission 1.0000 and 0.636 1.0000 and 0.537 1.00000 and 0.794
Refinement method Full-matrix least- Full-matrix least- Full-matrix least-
squares on F2 squares on F2 squares on F2
Data / restraints / parameters 5287/ 0 / 340 6793/ 0 / 349 4510 / 0 / 351
Goodness-of-fit on F2 1.056 1.064 1.039
Final R indices [I> 2sigma(I)] R1 = 0.0633, R1 = 0.0764, R1 = 0.0368,
wR2 = 0.1822 wR2 = 0.2321 wR2 = 0.1031
R indices (all data) R1 = 0.0674 , R1 = 0.0906, R1 = 0.0384,
wR2 = 0.1867 wR2 = 0.2451 wR2 = 0.1055
(fax: + (44)1223-336-033; email: deposit@ccdc.cam.
ac.uk).
3. Results and Discussion
3.1.1 Synthesis of compound 1a,b: The phosphin-
imine (1a,b) can be achieved in quantitative yield
by the treatment of respective imidazolin-2-imine and
chlorodiphenylphoshine in toluene solution at room
temperature and in the presence of triethylamine
(scheme 1).8 The conversion of imidazolin-2-imine to
(1a,b) can easily be detected by 1H and 31P{1H}NMR
spectroscopy. In 1H NMR, the gradual disappearance of
the singlet resonance for imine proton (NH) observed
for compound imidazolin-2-imine at δ 4.28 ppm (Mes)
4.21 ppm (Dipp) ensured the formation of related phos-
phinamine compound 1. A significant low field shift
[δ 6.59 ppm (1a) and 6.39 ppm (1b)] occurs for the res-
onances of olefinic NCH protons observed, compared
to that (δ 5.71 and 5.87 ppm) of free imidazolin-2-imine
reported by Tamm et al.9 In 31P{1H}NMR spectra, both
the compounds display a singlet resonance at δ 35.8
ppm (1a) and 27.8 ppm (1b) for the phosphorus atom
bound to imine nitrogen in. In addition, a marked low-
field shift of the NCN carbon atoms in 13C{1H}NMR
spectra, observed at δ 141.2 ppm (1a) and 148.5 ppm
(1b) indicate the formation of N-P bond in each case.
Re-crystallization of 1a from toluene furnished color-
less crystals, which were used for single crystal X-ray
diffraction analysis to establish the molecular structure
of 1a.
The solid state structure of 1a confirmed the for-
mation of phosphorus and nitrogen bond through the
elimination of triethylamine hydrochloride. The com-
pound 1a crystallizes in triclinic space group P 1
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Table 1. Crystallographic details of 1, 2a, 3a, 4a and 4b (contd).
Crystal 4a 4b
CCDC No. 1420031 1420032
Empirical formula C33H34N3PSe C39H46N3PSe
Formula weight 582.56 666.72
T (K) 293(2) 150(2)
λ (Å) 1.54184 1.54184
Crystal system Orthorhombic Monoclinic
Space group P212121 P21/c
a (Å) 8.9524(3) 11.5944(2)
b (Å) 18.2570(8) 15.0183(3)
c (Å) 18.5025(8) 21.3146(5)
α ( o) 90 90
β ( o) 90 108.205(2)
γ ( o) 90 90
V ( Å3) 3024.1(2) 3525.69(12)
Z 4 4
Dcalc Mg m−3 1.282 1.256
μ (mm−1) 2.366 2.092
F (000) 1212 1400
Theta range for data collection 3.40 to 71.11◦ 3.66 to 70.62◦.
Limiting indices −10<=h<=6, −13<=h<=14,
−22<=k<=18, −18<=k<=11,
−22<=l<=13 −24<=l<=26
Reflections collected / unique 8084 / 4885 [R(int) = 0.0243] 13913 / 6617[R(int) = 0.0328]
Completeness to theta 97.8% 97.6%
Absorption correction Multi-Scan Multi-Scan
Max. and min. transmission 1.000 and 0.552 1.00000 and 0.715
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data / restraints / parameters 4885 / 0 / 350 6617 / 0 / 405
Goodness-of-fit on F2 1.029 1.084
Final R indices [I>2sigma(I)] R1 = 0.0381, wR2 = 0.0989 R1 = 0.0355 , wR2 = 0.0978
R indices (all data) R1 = 0.0444, wR2 = 0.1059 R1 = 0.0379, wR2 = 0.1000
having two molecules in the unit cell. The molecular
structure of the compound 1a is shown in figure 1, and
selected bond lengths and angles are given in table 2.
The detailed structure and refinement parameters are
given in table 1.
The bond distance and bond angles are similar
to 1,3-di-tert-butyl-imidazolin-2-ylidine-1,1-diphenyl-
phosphinamine reported earlier by us.8 The carbon
nitrogen imine bond C1–N1 distance [1.301(3) Å] in 1a
is slightly increased with respect to the corresponding
free imidazolin-2-imine [1.289(2) Å] and silyl deriva-
tive (1.267(2) Å) reported in literature.13 This slight
elongation in C1–N1 bond length indicates that the
phosphinamine 1a exhibits presumably a stronger ylidic
behavior than their imine or silyl congeners. However,
C1-N2 [1.376(3) Å] and C1-N3 [1.384(3) Å] bond dis-
tances are within a similar range to that of free imines.
The phosphorus atom P1 lies 0.591 Å above the plane
drawn by the least square fit of the N1, C1, N2, N3,
C2 and C3 atoms of the molecule 1a indicating clear
Scheme 1. Synthesis of phosphinimines 1a,b from imidazolin-2-imine.




Figure 1. Solid state structures of compounds 1a, 2a, 3a, 4a and 4b; ellipsoids are drawn to encompass
30% probability. Selected bond lengths and bond angles are given in table 2.
Chalcogenide compounds of imidazolin-2-ylidene-1,1-diphenyl-phosphinamine
Table 2. Selected bond lengths [Å] and angles [◦] of compounds 1a, 2a, 3a, 4a and
4b.
1a 2a 3a 4a 4b
Bond Lengths (Å)
N1–C1 1.301(3) 1.292(4) 1.311(3) 1.306(4) 1.309(2)
N1–P1 1.674(2) 1.597(3) 1.6121(18) 1.609(3) 1.6070(1)
P1–E1 ——– 1.476(2) 1.9522(8) 2.1081(9) 2.1182(4)
C1–N2 1.376(3) 1.371(4) 1.359(3) 1.365(4) 1.372(2)
C1–N3 1.384(3) 1.368(4) 1.365(3) 1.356(4) 1.373(2)
N2–C2 1.403(3) 1.398(5) 1.390(3) 1.388(2) 1.388(2)
N3–C3 1.395(3) 1.399(5) 1.400(3) 1.396(2) 1.396(2)
C2–C3 1.330(3) 1.350(5) 1.320(4) 1.327(6) 1.345(2)
Bond Angles (◦)
C1–N1–P1 124.58(2) 138.9(3) 130.92(2) 132.2(3) 132.90(1)
N1–P1–E1 ——– 120.44(2) 119.36(7) 118.08(10) 118.42(5)
Ph–P1–Ph 97.06(1) 105.97(2) 101.82(9) 101.47(13) 103.83(8)
N2–C1–N3 104.65(2) 104.9(3) 131.3(2) 106.2(3) 105.31(1)
N1–C1–N2 132.5(2) 133.2(3) 122.5(2) 122.0(3) 123.57(1)
N1–C1–N3 122.8(2) 121.9(3) 106.08(2) 131.6(3) 130.84(1)
deviation from the co-planarity of P1 atoms from the imi-
dazole ring plane. The angle C1–N1–P1 [124.58(2)◦] is
considerably smaller than that present one in the corre-
sponding free silyl derivative 147.2(1)◦. The sum of the
angles around the C1 atom is 359.9◦.
3.1.2 Synthesis of oxo, sulfide and selenide compounds:
The corresponding sulfide (3a,b) and selenide (4a,b)
compounds were isolated in good yield through the
reaction of 1a,b with either elemental sulphur or sele-
nium in toluene under reflux condition (scheme 2).
However, the reaction of compound 1a,b with 30%
aqueous hydrogen peroxide in THF afforded the cor-
responding oxo-compound 2a,b in good yield (scheme
2). All the new compounds were characterized by spec-
troscopic and analytical techniques and the solid state
structures of compounds 2a, 3a, and 4a,b were estab-
lished by single crystal X-ray diffraction analysis.
In FT-IR spectra, the oxo compounds 2a and 2b dis-
play a strong absorption band at 1260 and 1224 cm−1,
respectively which can be assigned to P=O stretching
frequency of the corresponding compounds. Each of the
sulfide and selenide compounds 3a,b and 4a,b show
its characteristic strong absorption band (732 cm−1 for
3a, 728 for 3b, 965 cm−1 for 4a, 956 cm−1 for 4b)
for P=E (E = S, Se) bond stretching. The observed
values are in agreement with literature report.13 In 1H
NMR spectra, each compound displays characteristic
singlet resonance signals of two olefinic NCH protons
present in the imidazolium ring, (δ 6.47 ppm for 2a,
6.57 ppm for 2b, 6.77 ppm for 3a and 6.68 ppm for
3b, 6.60 ppm for 4a and 6.71 ppm for 4b) which falls
in the same range as compound 1a,b (δ 6.59 ppm and
Scheme 2. Synthesis of chalcogenide compounds 2a,b, 3a,b and 4a,b.
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6.39 ppm, respectively). Two separate sharp singlets
(δ 2.37, 2.05 ppm for 2a, 2.31, 2.18 ppm for 3a and
2.31, 2.21 ppm for 4a) with an integration ratio of 3:6
can be assigned to the methyl protons present in the
mesityl groups attached in imidazol rings of the com-
pounds 2a, 3a and 4a. The Dipp groups attached to
the imidazole rings of the compounds 2b, 3b and 4b
also show the characteristic resonance signals as one
septet (δ 2.86 ppm for 2b, 3.0 ppm for 3b and 3.05
ppm for 4b) and two doublets (δ 1.15, 1.04 ppm for
2b, 1.14, 1.13 ppm for 3b and 1.17, 1.14 ppm for 4b)
with average coupling constant of 6.8 Hz. 31P{1H}NMR
spectra are more informative as compounds 2a and 2b
show sharp peaks at δ 5.0 and 4.4 ppm, respectively,
which are slightly downfield shifted to that of simi-
lar compound CH2(6-t-Bu-4-MeC6H2O)2P(O)NMe2 (δ
1.6 ppm) reported by Chakravarty et al.14 Compounds
3a and 3b display sharp singlets at upfield region
δ 35.8 and 36.1 ppm, respectively, compared to that
of compound CH2(6-t-Bu-4-MeC6H2O)2P(S)NMe2(δ
73.8 ppm) synthesized by Chakravarty et al.14 In case
of compounds 4a and 4b, 31P{1H}NMR the resonance
peaks were observed at δ 25.7 and 26.2 ppm, respec-
tively, which are in same range to that of reported
compound cis-{(t-BuNH)P(Se)(μ-N-t-Bu)2P(O)H}.15
The resonance signals in the 13C{1H} are in the
expected ranges and match with the values reported in
literature.13
The compound 2a was crystallized from a solution
of CH2Cl2 and dioxane (2:1) at ambient temperature. In
solid state, the compound 2a crystallizes in monoclinic
space group P21/c having 4 molecules in the unit cell.
One dioxane molecule is also crystallized in the asym-
metric unit as solvate. The compounds 3a and 4a, each
crystallizes in orthorhombic space group P212121 hav-
ing four molecules in the unit cell. However, the com-
pound 4b crystallizes in monoclinic space group P21/c
having four molecules in the unit cell. The details of the
structural parameters are given in table 1 and the molec-
ular structures of the compounds 2a, 3a, 4a and 4b are
given in figure 1. The P-E (E = O, S, Se) bond distances
(1.476(2) Å for 2a and 1.952(8) Å for 3a, 2.108(9)
Å for 4a, 2.118(4) Å for 4b] (table 2) are well in




Å for [Ph2P(S)NHCPh3], 2.059(1) Å [CH2(6-t-
Bu-4-MeC2H2O)2P(O)NMe2]14 and 2.102(8) Å for
[Ph2P(Se)NH(2,6-Me2C6H3)], respectively, to consider
as phosphorus-chalcogen (O, S, Se) double bond.16,17
P-N bond distances 1.597(3) Å (2a), 1.612(2) Å (3a),
1.609(3) Å (4a) and 1.607(1) Å (4b) are similar and
slightly shorter than that of compound 1a [1.674(2)
Å]. Thus the shortening of the phosphorus nitro-
gen distances can be explained by the formation of
pπ-dπ bonding between lone pair of nitrogen and the
vacant d orbital of the adjacent phosphorus atom. Sim-
ilar observation was noticed in our previous results as
well.16,17
The C1-N1-P1 angles [138.9(3)◦ (2a), 130.9(2)◦
(3a), 132.2(3)◦ (4a) and 132.9(12)◦ (4b)] for the com-
pounds are similar but wider than that of compound 1a
[124.58(2)◦]. In comparison with reported N -silylated
imidazolin-2-imines [the C-N-Si angles range from
147(1) to 157.8(1)◦],8b analogous C1-N1-P1 angles are
more acute due to the attachment of the [P(E)Ph2]
fragment to the imine nitrogen. The N1-P1-E angles
[120.4(2)◦ (2a), 119.4(7)◦ (3a), 118.1(1)◦ (4a) and
118.4(5)◦ (4b)] are also very similar to each other
indicating a trigonal pyramidal geometry around the
phosphorus center in each compounds. The phospho-
rus atom P1 lies 0.07 Å (2a), 0.755 Å (3a), 0.738
Å (4a) and 0.912 Å (4b) above the plane drawn
by the least squares fit of the N3, C3, C2, N2, C1
and N1 atoms of each compound indicating near
coplanar geometry of the imidazole moiety with N1
and P1 atoms in compound 2a and much deviation
from co-planarity for other compounds. Even though
electronic factors might also be accounted, these devi-
ations in the position of the phosphorus atom with
respect to imidazolin-2-imine fragment clearly indi-
cate steric influence of the sulfur and selenium atom
attached to the phosphorus atom. Thus, deviation from
the C1-N1-P1 angle from linearity and the non-co-
planarity of the N1 and P1 atoms with the imidazole
ring for compounds 3a, 4a and 4b indicate that the delo-
calization of electrons from C1 carbon (formation of an
imidazolium cation) to phosphorus atom P1 via imine
nitrogen N1 to form a zwitter-ionic structure is absent.8
This is opposite to the observation of the imidazolin-
2-iminato metal complexes where imidazolin-2-iminato
serves as a six electron donor to the adjacent metal
center.5
4. Conclusions
In summary, we have successfully demonstrated the
synthesis and structural characterization of imidazolin-
2-iminophosphine and their oxo, sulfide and selenide
compounds. From their molecular structures in the
solid state we have observed that unlike imdazolin-2-
imines, the delocalization cannot be extended from the
imidazole ring to the phosphorus atom through imine
nitrogen.
Chalcogenide compounds of imidazolin-2-ylidene-1,1-diphenyl-phosphinamine
Supplementary Information (SI)
The 1H and 31P{1H}NMR spectra of compounds 1a, 1b,
2a, 2b, 3a, 3b, 4a and 4b are given in Supplementary
Information, available at www.ias.ac.in/chemsci.
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